NZ217331A - Tissue plasminogen activator derivatives and genetically engineered product - Google Patents
Tissue plasminogen activator derivatives and genetically engineered productInfo
- Publication number
- NZ217331A NZ217331A NZ217331A NZ21733186A NZ217331A NZ 217331 A NZ217331 A NZ 217331A NZ 217331 A NZ217331 A NZ 217331A NZ 21733186 A NZ21733186 A NZ 21733186A NZ 217331 A NZ217331 A NZ 217331A
- Authority
- NZ
- New Zealand
- Prior art keywords
- genetically engineered
- plasminogen activator
- tissue plasminogen
- engineered product
- activator derivatives
- Prior art date
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US76929885A | 1985-08-26 | 1985-08-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ217331A true NZ217331A (en) | 1989-05-29 |
Family
ID=25085053
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ217331A NZ217331A (en) | 1985-08-26 | 1986-08-22 | Tissue plasminogen activator derivatives and genetically engineered product |
Country Status (3)
Country | Link |
---|---|
JP (1) | JPS6248378A (en) |
AU (1) | AU603062B2 (en) |
NZ (1) | NZ217331A (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR950000303B1 (en) * | 1985-12-20 | 1995-01-13 | 디 엎죤 캄파니 | How to prepare a tissue plasminogen activating factor (TPA) analog |
CA1341444C (en) * | 1986-01-24 | 2003-10-21 | Margaret Y. Insley | Modified tissue plasminogen activator |
US5149533A (en) * | 1987-06-04 | 1992-09-22 | Zymogenetics, Inc. | Modified t-PA with kringle-/replaced by another kringle |
SE8702562L (en) * | 1987-06-18 | 1988-12-19 | Kabigen Ab | NEW FIBRINOLYTIC ENZYMES |
EP0365597B2 (en) * | 1987-06-30 | 2005-02-09 | Genentech, Inc. | Improved processes for the treatment of vascular disease |
JP2708749B2 (en) * | 1987-08-10 | 1998-02-04 | エーザイ株式会社 | Injectable composition containing modified tPA |
US5244676A (en) * | 1987-10-09 | 1993-09-14 | Monsanto Company | Modified tissue plasminogen activator with modified glycosylation site |
KR970005046B1 (en) * | 1987-10-29 | 1997-04-11 | 야마노우찌 세이야꾸 가부시끼가이샤 | Modified tissue plasminogen activator |
US5037646A (en) * | 1988-04-29 | 1991-08-06 | Genentech, Inc. | Processes for the treatment of vascular disease |
US6280540B1 (en) * | 1994-07-22 | 2001-08-28 | Haynes International, Inc. | Copper-containing Ni-Cr-Mo alloys |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IE56716B1 (en) * | 1983-01-19 | 1991-11-20 | Genentech Inc | Method for producing human tpa and expression vectors therefor |
JP4331573B2 (en) * | 2003-11-07 | 2009-09-16 | 株式会社ニューギン | Game machine |
JP2008054766A (en) * | 2006-08-29 | 2008-03-13 | Samii Kk | Pachinko game machine |
JP5384301B2 (en) * | 2009-11-12 | 2014-01-08 | 株式会社三共 | Game machine |
-
1986
- 1986-08-22 NZ NZ217331A patent/NZ217331A/en unknown
- 1986-08-25 AU AU61804/86A patent/AU603062B2/en not_active Ceased
- 1986-08-26 JP JP61201225A patent/JPS6248378A/en active Pending
Also Published As
Publication number | Publication date |
---|---|
AU6180486A (en) | 1987-03-05 |
JPS6248378A (en) | 1987-03-03 |
AU603062B2 (en) | 1990-11-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2179948B (en) | Poly-kringle plasminogen activator | |
IL89194A0 (en) | Carcass chiller and sterilizer | |
AU4777785A (en) | Modified tissue plasminogen activators | |
NZ215660A (en) | Tissue plasminogen activator modified in the growth factor domain | |
AU5330286A (en) | Modified tissue-type plasminogen activator | |
NZ216306A (en) | Pharmaceutical compositions containing tissue plasminogen activator | |
IL78938A0 (en) | Pharmaceutical composition containing tissue plasminogen activator and its preparation | |
AU6806487A (en) | Tissue plasminogen activator | |
IL82272A0 (en) | Tissue-type plasminogen activator and process for preparation thereof | |
NZ217331A (en) | Tissue plasminogen activator derivatives and genetically engineered product | |
EP0313969A3 (en) | Tripeptide derivatives and antiplasmin agents containing the same | |
IL91774A0 (en) | Preparation of plasminogen activator expressed in prokaryotes | |
EP0255695A3 (en) | P-hydroxycinnamamide derivatives and melanin inhibitor comprising the same | |
ZA866196B (en) | Novel quinaldinamide derivatives and their preparations | |
ZA863956B (en) | Pharmaceutical formulations containing tissue plasminogen activator | |
EP0337817A3 (en) | Plasminogen activator and thrombolytic agent | |
AU7090787A (en) | Tissue plasminogen activator | |
GB8815245D0 (en) | New tissue plasminogen activator | |
ZA862976B (en) | Human tissue plasminogen activator mutants | |
IE870208L (en) | Modified tissue plasminogen activator | |
NZ223291A (en) | Modified tissue-type plasminogen activator | |
AU608232C (en) | Modified tissue plasminogen activator | |
GB8826692D0 (en) | Tissue plasminogen activator | |
IE883342L (en) | Human tissue-type plasminogen activator variant | |
GB8725052D0 (en) | Tissue plasminogen activator |